FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Knud Kragballe

Research Profile

Disorders

Psoriasis

Chemicals & Drugs

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Knud Kragballe; Mark Lebwohl; Alan Menter; Paul W Tebbey; Peter C M van de Kerkhof
Long-term management of scalp psoriasis: perspectives from the international psoriasis council.
Rosa M Andrés; Anne Hald; Claus Johansen; Knud Kragballe; Lars Iversen
Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity.
Anne Gedebjerg; Claus Johansen; Knud Kragballe; Lars Iversen
IL-20, IL-21 and p40: potential biomarkers of treatment response for ustekinumab.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Knud Kragballe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Knud Kragballe; Mark Lebwohl; Alan Menter; Paul W Tebbey; Peter C M van de Kerkhof
Long-term management of scalp psoriasis: perspectives from the international psoriasis council.
The Journal of dermatological treatment 2013;24(3):188-92.
2013: Rosa M Andrés; Anne Hald; Claus Johansen; Knud Kragballe; Lars Iversen
Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity.
Experimental dermatology 2013;22(5):323-8.
2013: Anne Gedebjerg; Claus Johansen; Knud Kragballe; Lars Iversen
IL-20, IL-21 and p40: potential biomarkers of treatment response for ustekinumab.
Acta dermato-venereologica 2013;93(2):150-5.
2013: R B Kjellerup; Knud Kragballe; Claus Johansen; Lars Iversen
The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin.
The British journal of dermatology 2013;168(2):339-45.
2012: Inge Nordgaard-Lassen; Pernille Ravn; Inge Juul Sørensen; Klaus Theede; Lone Tjellesen; Erika Belard; Jens Frederik Dahlerup; Jan Gerstoft; Jens Kjeldsen; Knud Kragballe
Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment.
Danish medical journal 2012;59(7):C4480.
2012: Rune Lindberg-Larsen; Henrik Sølvsten; Knud Kragballe
Evaluation of recurrence after photodynamic therapy with topical methylaminolaevulinate for 157 basal cell carcinomas in 90 patients.
Acta dermato-venereologica 2012;92(2):144-7.
2011: Jette Lindorff Riis; Christian Vestergaard; Claus Johansen; Knud Kragballe; Kristian Otkjaer; Lars Iversen
CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways.
Cytokine 2011;56(3):699-707.
2011: Jette L Riis; Christian Vestergaard; Rikke Bech; Claus Johansen; Knud Kragballe; Lars Iversen
Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis.
Experimental dermatology 2011;20(10):789-94.
2011: Claus Johansen; Knud Kragballe; Jette L Riis; Anne Gedebjerg; Lars Iversen
Tumor necrosis factor α-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor κB.
The Journal of biological chemistry 2011;286(29):25487-94.
2011: Borbala Gesser; Claus Johansen; R B Kjellerup; Knud Kragballe; L Raaby; M K Rasmussen; Cecilia Rosada; Lars Iversen
Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2011;60(7):643-53.
2011: Louise L Lilleholt; Claus Johansen; J Simon Arthur; Anne Funding; Bo M Bibby; Knud Kragballe; Lars Iversen
Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-O-tetradecanoylphorbol 13-acetate.
Acta dermato-venereologica 2011;91(3):271-8.
2011: Robert Gniadecki; Knud Kragballe; T N Dam; Lone Skov
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris.
The British journal of dermatology 2011;164(5):1091-6.
2011: Simon Chang; Lars Iversen; Knud Kragballe; J Simon C Arthur; Claus Johansen
Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model.
Cancer investigation 2011;29(3):240-5.
2011: Maria L Salskov-Iversen; Claus Johansen; Knud Kragballe; Lars Iversen
Caspase-5 expression is upregulated in lesional psoriatic skin.
The Journal of investigative dermatology 2011;131(3):670-6.
2011: Trine Bertelsen; Lars Iversen; Jette Lindorff Riis; J Simon C Arthur; Bo Martin Bibby; Knud Kragballe; Claus Johansen
The role of mitogen- and stress-activated protein kinase 1 and 2 in chronic skin inflammation in mice.
Experimental dermatology 2011;20(2):140-5.
2010: Claus Johansen; H Vinter; L Soegaard-Madsen; L R Olsen; Torben Steiniche; Lars Iversen; Knud Kragballe
Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
The British journal of dermatology 2010;163(6):1194-204.
2010: Mona Ståhle; Nilgun Atakan; Wolf-Henning Boehncke; Sergio Chimenti; Esteban Daudén; Alberto Giannetti; Peter Hoeger; Pascal Joly; andreas katsabas; Knud Kragballe; Jo Lambert; Jean-Paul Ortonne; Joerg C Prinz; Lluís Puig; Marieke Seyger; Robert Strohal; Peter Van De Kerkhoff; Wolfram Sterry
Juvenile psoriasis and its clinical management: a European expert group consensus.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2010;8(10):812-8.
2010: Annette Ostergaard Jensen; Claus Svaerke; Dora Farkas; Lars Pedersen; Knud Kragballe; Henrik Toft Sørensen
Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
Acta dermato-venereologica 2010;90(5):474-9.
2010: L Soegaard-Madsen; Claus Johansen; Lars Iversen; Knud Kragballe
Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement.
The British journal of dermatology 2010;162(6):1216-23.
2010: Kristian Otkjaer; Helmut Holtmann; Tue Wenzel Kragstrup; Søren R Paludan; Claus Johansen; Matthias Gaestel; Knud Kragballe; Lars Iversen
The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.
PloS one 2010;5(1):e8671.
2009: Claus Johansen; Christian Vestergaard; Knud Kragballe; George Kollias; Matthias Gaestel; Lars Iversen
MK2 regulates the early stages of skin tumor promotion.
Carcinogenesis 2009;30(12):2100-8.
2009: R B Kjellerup; Lars Iversen; Knud Kragballe; Claus Johansen
The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin.
The British journal of dermatology 2009;161(5):1059-66.
2009: Knud Kragballe; V Hoffmann; J P Ortonne; J Tan; P Nordin; S Segaert
Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
The British journal of dermatology 2009;161(1):159-66.
2009: Anne T Funding; Claus Johansen; Matthias Gaestel; Bo M Bibby; Louise L Lilleholt; Knud Kragballe; Lars Iversen
Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice.
The Journal of investigative dermatology 2009;129(4):891-8.
2009: Claus Johansen; P A Usher; R B Kjellerup; D Lundsgaard; Lars Iversen; Knud Kragballe
Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
The British journal of dermatology 2009;160(2):319-24.
2009: Karin Stenderup; Cecilia Rosada; Anne Worsaae; F Dagnaes-Hansen; Torben Steiniche; E Hasselager; L F Iversen; S Zahn; H Wöldike; H Lindgreen Holmberg; J Rømer; Knud Kragballe; Jes Thorn Clausen; T N Dam
Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model.
The British journal of dermatology 2009;160(2):284-96.
2009: Knud Kragballe
Management of difficult to treat locations of psoriasis. Scalp, face, flexures, palm/soles and nails.
Current problems in dermatology 2009;38():160-71.
2009: Wolfram Sterry; Martine Bagot; Carlos Ferrandiz; Knud Kragballe; Kim Papp; Georg Stingl
Immunosuppressive therapy in dermatology and PML.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2009;7(1):5.
2008: M K Rasmussen; Lars Iversen; Claus Johansen; J Finnemann; L S Olsen; Knud Kragballe; Borbala Gesser
IL-8 and p53 are inversely regulated through JNK, p38 and NF-kappaB p65 in HepG2 cells during an inflammatory response.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2008;57(7):329-39.
2008: Knud Kragballe; Bent Deleuran
[Biological treatment of psoriasis and psoriatic arthritis].
Ugeskrift for laeger 2008;170(24):2148-50.
2008: Rasmus Boye Kjellerup; Knud Kragballe; Lars Iversen; Claus Johansen
Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases.
Experimental dermatology 2008;17(6):498-504.
2007: Claus Johansen; Kristine Moeller; Knud Kragballe; Lars Iversen
The activity of caspase-1 is increased in lesional psoriatic epidermis.
The Journal of investigative dermatology 2007;127(12):2857-64.
2007: Borbala Gesser; Claus Johansen; Mads K Rasmussen; Anne T Funding; Kristian Otkjaer; Rasmus B Kjellerup; Knud Kragballe; Lars Iversen
Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.
The Journal of investigative dermatology 2007;127(9):2129-37.
2007: Anne T Funding; Claus Johansen; Knud Kragballe; Lars Iversen
Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis.
The Journal of investigative dermatology 2007;127(8):2012-9.
2007: Kristian Otkjaer; Knud Kragballe; Claus Johansen; Anne T Funding; Helle Just; Uffe B Jensen; Lotte G Sørensen; Peder L Nørby; Jes Thorn Clausen; Lars Iversen
IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms.
The Journal of investigative dermatology 2007;127(6):1326-36.
2007: Knud Kragballe
Efalizumab in the treatment of chronic plaque psoriasis: experiences from the largest psoriasis treatment centre in Denmark.
The British journal of dermatology 2007;156 Suppl 2():7-11.
2007: Lars Iversen; Knud Kragballe
[Biological dermatologic agents. The Danish Society of Dermatology].
Ugeskrift for laeger 2007;169(12):1100.
2007: Knud Kragballe; Linda Corvari
An innovation in topical therapy: insights from international dermatologists.
Cutis; cutaneous medicine for the practitioner 2007;79(1 Suppl 2):39-45.
2006: Alex V Anstey; Knud Kragballe
Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
International journal of dermatology 2006;45(8):970-5.
2006: Anne T Funding; Claus Johansen; Knud Kragballe; Kristian Otkjaer; Uffe B Jensen; Mogens W Madsen; Marianne Scheel Fjording; Jørgen Finnemann; Tine Skak-Nielsen; Søren R Paludan; Lars Iversen
Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines.
The Journal of investigative dermatology 2006;126(8):1784-91.
2006: Knud Kragballe; Joar Austad; L Barnes; Adrian Bibby; Michel de la Brassinne; Frédéric Cambazard; C Fleming; H Heikkilä; D Jolliffe; J Peyri; A Svensson; J Toole; Gottfried Wozel
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
The British journal of dermatology 2006;154(6):1155-60.
2006: P C M van de Kerkhof; Knud Kragballe; Joar Austad; John Berth-Jones; Frédéric Cambazard; Michel de la Brassinne; Anders Ljungberg; Gillian Murphy; Kim Papp; Gottfried Wozel
Psoriasis: severity assessment in clinical practice. Conclusions from workshop discussions and a prospective multicentre survey of psoriasis severity.
European journal of dermatology : EJD 2006;16(2):167-71.
2006: Claus Johansen; Anne T Funding; Kristian Otkjaer; Knud Kragballe; Uffe B Jensen; Mogens Madsen; Lise Binderup; Tine Skak-Nielsen; Marianne Scheel Fjording; Lars Iversen
Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(3):1431-8.
2006: Knud Kragballe; Joar Austad; L Barnes; Adrian Bibby; Michel de la Brassinne; Frédéric Cambazard; C Fleming; H Heikkilä; Z Williams; J Peyri Rey; A Svensson; J Toole; Gottfried Wozel
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
Dermatology (Basel, Switzerland) 2006;213(4):319-26.
2005: Kristian Otkjaer; Knud Kragballe; Anne T Funding; Jes Thorn Clausen; P L Noerby; Torben Steiniche; Lars Iversen
The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.
The British journal of dermatology 2005;153(5):911-8.
2005: Knud Kragballe
[Quality and documentation prior to dermatological laser treatment].
Ugeskrift for laeger 2005;167(43):4063.
2005: Claus Johansen; Esben Flindt; Knud Kragballe; Jeanette Henningsen; Majken Westergaard; Karsten Kristiansen; Lars Iversen
Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
The Journal of investigative dermatology 2005;124(6):1284-92.
2005: Anette Bygum; Regina C Betz; Knud Kragballe; Torben Steiniche; Nils Peeters; Wim Wuyts; Markus M Nöthen
KID Syndrome: report of a Scandinavian patient with connexin-26 gene mutation.
Acta dermato-venereologica 2005;85(2):152-5.
2005: Lars Iversen; Claus Johansen; Knud Kragballe
Signal transduction pathways in human epidermis.
European journal of dermatology : EJD 2005;15(1):4-12.
2005: Claus Johansen; Knud Kragballe; Majken Westergaard; Jeanette Henningsen; Karsten Kristiansen; Lars Iversen
The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin.
The British journal of dermatology 2005;152(1):37-42.
2004: Jette L Riis; Claus Johansen; Borbala Gesser; Kristine Møller; Christian Groenhoej Larsen; Knud Kragballe; Lars Iversen
1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression.
Archives of dermatological research 2004;296(5):195-202.
2004: Claus Johansen; Knud Kragballe; M Rasmussen; T N Dam; Lars Iversen
Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
The British journal of dermatology 2004;151(3):600-7.
2004: Wolfram Sterry; J Barker; Wolf-Henning Boehncke; J D Bos; S Chimenti; Enno Christophers; Michel de la Brassinne; C Ferrandiz; Christopher E M Griffiths; A Katsambas; Knud Kragballe; Charles Lynde; Alan Menter; J-P Ortonne; K Papp; J Prinz; Berthold Rzany; J Ronnevig; Jean-Hilaire Saurat; M Stahle; F M Stengel; P Van De Kerkhof; John J Voorhees
Biological therapies in the systemic management of psoriasis: International Consensus Conference.
The British journal of dermatology 2004;151 Suppl 69():3-17.
2004: Knud Kragballe; K L Noerrelund; H Lui; J P Ortonne; Gottfried Wozel; T Uurasmaa; C Fleming; J L López Estebaranz; L I Hanssen; L-M Persson
Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
The British journal of dermatology 2004;150(6):1167-73.
2004: Karsten Fogh; Knud Kragballe
New vitamin D analogs in psoriasis.
Current drug targets. Inflammation and allergy 2004;3(2):199-204.
2004: Anette Bygum; Hugh Zachariae; Jørn Dyerberg; Knud Kragballe
[Hereditary angioedema].
Ugeskrift for laeger 2004;166(5):362-6.
2004: Ane Kaltoft Ryborg; Claus Johansen; Lars Iversen; Knud Kragballe
Lysophosphatidylcholine induces keratinocyte differentiation and upregulation of AP-1- and NF-kappaB DNA-binding activity.
Acta dermato-venereologica 2004;84(6):433-8.
2003: John Rømer; Erik Hasselager; Peder L Nørby; Torben Steiniche; Jes Thorn Clausen; Knud Kragballe
Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol.
The Journal of investigative dermatology 2003;121(6):1306-11.
2003: Majken Westergaard; Jeanette Henningsen; Claus Johansen; Sofie Rasmussen; Morten Lyhne Svendsen; Uffe B Jensen; Henrik Daa Schrøder; Bart Staels; Lars Iversen; Lars Bolund; Knud Kragballe; Karsten Kristiansen
Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin.
The Journal of investigative dermatology 2003;121(5):1104-17.
2003: Lone Skov; Knud Kragballe; Claus Zachariae; Erik R Obitz; Elisabeth A Holm; Gregor Jemec; Henrik Sølvsten; Hans H Ibsen; Lone Knudsen; Pia Jensen; Jan H Petersen; Torkil Menné; Ole Baadsgaard
HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris.
Archives of dermatology 2003;139(11):1433-9.
2003: Claus Johansen; Knud Kragballe; Lars Iversen
Growth medium-dependent ERK1/2 and AP-1 activity in cultured normal human keratinocytes modulates 1alpha,25-dihydroxyvitamin D3-induced differentiation.
Archives of dermatological research 2003;295(5):199-202.
2003: Claus Johansen; Knud Kragballe; Jeanette Henningsen; Majken Westergaard; Karsten Kristiansen; Lars Iversen
1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes.
The Journal of investigative dermatology 2003;120(4):561-70.
2002: Knud Kragballe
Vitamin D and UVB radiation therapy.
Cutis; cutaneous medicine for the practitioner 2002;70(5 Suppl):9-12.
2002: P C M van de Kerkhof; C Green; Karin Hamberg; P E Hutchinson; J K Jensen; P Kidson; Knud Kragballe; F G Larsen; C S Munro; D M Tillman
Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis.
Dermatology (Basel, Switzerland) 2002;204(3):214-21.
2001: Majken Westergaard; Jeanette Henningsen; Morten Lyhne Svendsen; Claus Johansen; Uffe B Jensen; Henrik Daa Schrøder; Irina Kratchmarova; Rolf K Berge; Lars Iversen; Lars Bolund; Knud Kragballe; Karsten Kristiansen
Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid.
The Journal of investigative dermatology 2001;116(5):702-12.
2000: Karsten Fogh; Knud Kragballe
Eicosanoids in inflammatory skin diseases.
Prostaglandins & other lipid mediators 2000;63(1-2):43-54.
2000: L Iversen; Knud Kragballe
Arachidonic acid metabolism in skin health and disease.
Prostaglandins & other lipid mediators 2000;63(1-2):25-42.
2000: Ane Kaltoft Ryborg; B Deleuran; H Søgaard; Knud Kragballe
Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes.
Acta dermato-venereologica 2000;80(4):242-6.
2000: Claus Johansen; Lars Iversen; Ane Kaltoft Ryborg; Knud Kragballe
1alpha,25-dihydroxyvitamin D3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity.
The Journal of investigative dermatology 2000;114(6):1174-9.
2000: Karsten Fogh; Knud Kragballe
Recent developments in vitamin D analogs.
Current pharmaceutical design 2000;6(9):961-72.
1999: JB Nissen; Henrik Egekvist; Peter Bjerring; Knud Kragballe
Effect of intradermal injection of methionine-enkephalin on human skin.
Acta dermato-venereologica 1999;79(1):23-6.
1999: JB Nissen; W W Avrach; E S Hansen; K Stengaard-Pedersen; Knud Kragballe
Decrease in enkephalin levels in psoriatic lesions after calcipotriol and mometasone furoate treatment.
Dermatology (Basel, Switzerland) 1999;198(1):11-7.
1998: JB Nissen; W W Avrach; E S Hansen; K Stengaard-Pedersen; Knud Kragballe
Increased levels of enkephalin following natural sunlight (combined with salt water bathing at the Dead Sea) and ultraviolet A irradiation.
The British journal of dermatology 1998;139(6):1012-9.
1998: Knud Kragballe; L Barnes; Karin Hamberg; P Hutchinson; F Murphy; S Møller; T Ruzicka; P C Van De Kerkhof
Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy.
The British journal of dermatology 1998;139(4):649-54.
1998: Hugh Zachariae; Knud Kragballe; Hans Erik Hansen; Niels Marcussen; S Olsen
[Renal biopsy in connection with long-term treatment of psoriasis with cyclosporine].
Ugeskrift for laeger 1998;160(31):4534-8.
1998: T J Jensen; L O Henriksen; Henrik Sølvsten; Knud Kragballe
Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
Biochemical pharmacology 1998;55(6):767-73.
1998: T Jensen; S Sørensen; Henrik Sølvsten; Knud Kragballe
The vitamin D3 receptor and retinoid X receptors in psoriatic skin: the receptor levels correlate with the receptor binding to DNA.
The British journal of dermatology 1998;138(2):225-8.
1997: JB Nissen; Knud Kragballe
Enkephalins modulate differentiation of normal human keratinocytes in vitro.
Experimental dermatology 1997;6(5):222-9.
1997: Knud Kragballe
The future of vitamin D in dermatology.
Journal of the American Academy of Dermatology 1997;37(3 Pt 2):S72-6.
1997: Karsten Fogh; Knud Kragballe
Vitamin D3 analogues.
Clinics in dermatology 1997;15(5):705-13.
1997: Henrik Sølvsten; Morten Lyhne Svendsen; Karsten Fogh; Knud Kragballe
Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes.
Archives of dermatological research 1997;289(6):367-72.
1997: JB Nissen; M Lund; K Stengaard-Pedersen; Knud Kragballe
Enkephalin-like immunoreactivity in human skin is found selectively in a fraction of CD68-positive dermal cells: increase in enkephalin-positive cells in lesional psoriasis.
Archives of dermatological research 1997;289(5):265-71.
1997: Hugh Zachariae; Knud Kragballe; Hans Erik Hansen; Niels Marcussen; S Olsen
Renal biopsy findings in long-term cyclosporin treatment of psoriasis.
The British journal of dermatology 1997;136(4):531-5.
1997: L Iversen; Knud Kragballe; V A Ziboh
Significance of leukotriene-A4 hydrolase in the pathogenesis of psoriasis.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1997;10(4):169-77.
1997: S Sørensen; Henrik Sølvsten; Y Politi; Knud Kragballe
Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1997;10(3):144-52.
1997: Morten Lyhne Svendsen; G Daneels; Johan JGH Geysen; L Binderup; Knud Kragballe
Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
Pharmacology & toxicology 1997;80(1):49-56.
1996: L Iversen; Morten Lyhne Svendsen; Knud Kragballe
Cyclosporin A down-regulates the LTA4 hydrolase level in human keratinocyte cultures.
Acta dermato-venereologica 1996;76(6):424-8.
1996: L Iversen; Bent Deleuran; A M Hoberg; Knud Kragballe
LTA4 hydrolase in human skin: decreased activity, but normal concentration in lesional psoriatic skin. Evidence for different LTA4 hydrolase activity in human lymphocytes and human skin.
Archives of dermatological research 1996;288(5-6):217-24.
1996: T N Dam; Bjarne Møller; J Hindkjaer; Knud Kragballe
The vitamin D3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 1996;1(1):72-7.
1996: Henrik Sølvsten; Karsten Fogh; Morten Lyhne Svendsen; P Kristensen; A Aström; R Kumar; Knud Kragballe
Normal levels of the vitamin D receptor and its message in psoriatic skin.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 1996;1(1):28-32.
1996: Karsten Fogh; Henrik Sølvsten; H Jøhnke; Knud Kragballe
All-trans retinoic acid inhibits binding of 1,25-dihydroxy-vitamin D3 to the vitamin D receptor in cultured human keratinocytes.
Experimental dermatology 1996;5(1):24-7.
1995: JB Nissen; L Iversen; Knud Kragballe
Characterization of the aminopeptidase activity of epidermal leukotriene A4 hydrolase against the opioid dynorphin fragment 1-7.
The British journal of dermatology 1995;133(5):742-9.
1995: Knud Kragballe
Vitamin D3 analogues.
Dermatologic clinics 1995;13(4):835-9.
1995: A K Ryborg; B Grøn; Knud Kragballe
Increased lysophosphatidylcholine content in lesional psoriatic skin.
The British journal of dermatology 1995;133(3):398-402.
1995: Bent Deleuran; L Iversen; Mette Deleuran; H Yssel; Knud Kragballe; Kristian Stengaard-Pedersen; Kristian Thestrup-Pedersen
Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13.
Cytokine 1995;7(4):319-24.
1995: J Heitmann; L Iversen; Knud Kragballe; V A Ziboh
Incorporation of 15-hydroxyeicosatrienoic acid in specific phospholipids of cultured human keratinocytes and psoriatic plaques.
Experimental dermatology 1995;4(2):74-8.
1995: L Iversen; P Kristensen; JB Nissen; William C Merrick; Knud Kragballe
Purification and characterization of leukotriene A4 hydrolase from human epidermis.
FEBS letters 1995;358(3):316-22.
1994: Knud Kragballe; T N Dam; E R Hansen; Ole Baadsgaard; F Grønhøj Larsen; J Søndergaard; M B Axelsen
Efficacy and safety of the 20-epi-vitamin D3 analogue KH 1060 in the topical therapy of psoriasis: results of a dose-ranging study.
Acta dermato-venereologica 1994;74(5):398-402.
1994: Bent Deleuran; L Iversen; M Kristensen; M Field; Knud Kragballe; Kristian Thestrup-Pedersen; Kristian Stengaard-Pedersen
Interleukin-8 secretion and 15-lipoxygenase activity in rheumatoid arthritis: in vitro anti-inflammatory effects by interleukin-4 and interleukin-10, but not by interleukin-1 receptor antagonist protein.
British journal of rheumatology 1994;33(6):520-5.
1994: L Iversen; V A Ziboh; T Shimizu; N Ohishi; O Rådmark; Anders Wetterholm; Knud Kragballe
Identification and subcellular localization of leukotriene A4-hydrolase activity in human epidermis.
Journal of dermatological science 1994;7(3):191-201.
1994: L Iversen; P Kristensen; B Grøn; V A Ziboh; Knud Kragballe
Human epidermis transforms exogenous leukotriene A4 into peptide leukotrienes: possible role in transcellular metabolism.
Archives of dermatological research 1994;286(5):261-6.
1994: A K Ryborg; Bent Deleuran; Kristian Thestrup-Pedersen; Knud Kragballe
Lysophosphatidylcholine: a chemoattractant to human T lymphocytes.
Archives of dermatological research 1994;286(8):462-5.
1993: Karsten Fogh; L Iversen; Troels Herlin; Knud Kragballe
Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
Acta dermato-venereologica 1993;73(3):191-3.
1993: Frederik Grønhøj Larsen; P Jakobsen; J Knudsen; Kaare Weismann; Knud Kragballe; F Nielsen-Kudsk
Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol.
The Journal of investigative dermatology 1993;100(5):623-7.
1993: L Iversen; Karsten Fogh; V A Ziboh; P Kristensen; A Schmedes; Knud Kragballe
Leukotriene B4 formation during human neutrophil keratinocyte interactions: evidence for transformation of leukotriene A4 by putative keratinocyte leukotriene A4 hydrolase.
The Journal of investigative dermatology 1993;100(3):293-8.
1993: B Grøn; L Iversen; V Ziboh; Knud Kragballe
Distribution of monohydroxy fatty acids in specific human epidermal phospholipids.
Experimental dermatology 1993;2(1):38-44.
1993: Knud Kragballe; L Iversen
Calcipotriol. A new topical antipsoriatic.
Dermatologic clinics 1993;11(1):137-41.
1993: B Grøn; L Iversen; V Ziboh; Knud Kragballe
Monohydroxy fatty acids esterified to phospholipids are decreased in lesional psoriatic skin.
Archives of dermatological research 1993;285(8):449-54.
1992: Knud Kragballe
Treatment of psoriasis with calcipotriol and other vitamin D analogues.
Journal of the American Academy of Dermatology 1992;27(6 Pt 1):1001-8.
1992: Frederik Grønhøj Larsen; F Nielsen-Kudsk; P Jakobsen; Kaare Weismann; Knud Kragballe
Pharmacokinetics and therapeutic efficacy of retinoids in skin diseases.
Clinical pharmacokinetics 1992;23(1):42-61.
1992: Hugh Zachariae; H E Hansen; Knud Kragballe; S Olsen
Morphologic renal changes during cyclosporine treatment of psoriasis. Studies on pretreatment and posttreatment kidney biopsy specimens.
Journal of the American Academy of Dermatology 1992;26(3 Pt 2):415-9.
1992: Karsten Fogh; C G Larsen; L Iversen; Knud Kragballe
Interleukin-8 stimulates the formation of 15-hydroxy-eicosatetraenoic acid by human neutrophils in vitro.
Agents and actions 1992;35(3-4):227-31.
1992: Frederik Grønhøj Larsen; C Vahlquist; E Andersson; H Törma; Knud Kragballe; Anders Vahlquist
Oral acitretin in psoriasis: drug and vitamin A concentrations in plasma, skin and adipose tissue.
Acta dermato-venereologica 1992;72(2):84-8.
1992: J Christophersen; J M Geiger; P Danneskiold-Samsoe; Knud Kragballe; F G Larsen; G Laurberg; J Serup; K Thomsen
A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease.
Acta dermato-venereologica 1992;72(2):150-2.
1992: Knud Kragballe
Vitamin D3 and skin diseases.
Archives of dermatological research 1992;284 Suppl 1():S30-6.
1992: L Iversen; Karsten Fogh; Knud Kragballe
Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway.
Archives of dermatological research 1992;284(4):222-6.
1991: L Iversen; Karsten Fogh; G Bojesen; Knud Kragballe
Linoleic acid and dihomogammalinolenic acid inhibit leukotriene B4 formation and stimulate the formation of their 15-lipoxygenase products by human neutrophils in vitro. Evidence of formation of antiinflammatory compounds.
Agents and actions 1991;33(3-4):286-91.
1991: Frederik Grønhøj Larsen; P Jakobsen; H Eriksen; J Grønhøj; Knud Kragballe; F Nielsen-Kudsk
The pharmacokinetics of acitretin and its 13-cis-metabolite in psoriatic patients.
Journal of clinical pharmacology 1991;31(5):477-83.
1991: Knud Kragballe; B T Gjertsen; D De Hoop; T Karlsmark; P C van de Kerkhof; O Larkö; C Nieboer; J Roed-Petersen; A Strand; G Tikjøb
Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris.
Lancet 1991;337(8735):193-6.
1991: Knud Kragballe; Frederik Grønhøj Larsen
A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis.
Acta dermato-venereologica 1991;71(6):540-2.
1991: Knud Kragballe; Karsten Fogh; H Søgaard
Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study.
Acta dermato-venereologica 1991;71(6):475-8.
1990: Frederik Grønhøj Larsen; F Nielsen-Kudsk; P Jakobsen; H Schrøder; Knud Kragballe
Interaction of etretinate with methotrexate pharmacokinetics in psoriatic patients.
Journal of clinical pharmacology 1990;30(9):802-7.
1990: A Andreasen; Ebbe S Hansen; Karsten Fogh; Knud Kragballe; Troels Herlin
Proliferation of adherent synovial fluid cell cultures is modified by eicosanoids.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1990;98(7):605-8.
1990: Ebbe S Hansen; Karsten Fogh; Vibeke E Hjortdal; T B Henriksen; I Noer; Henrik Ewald; Troels Herlin; Knud Kragballe; C Bünger
Synovitis reduced by inhibition of leukotriene B4. Carrageenan-induced gonarthritis studied in dogs.
Acta orthopaedica Scandinavica 1990;61(3):207-12.
1990: Knud Kragballe
Combination of topical calcipotriol (MC 903) and UVB radiation for psoriasis vulgaris.
Dermatologica 1990;181(3):211-4.
1990: Knud Kragballe; I L Wildfang
Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes.
Archives of dermatological research 1990;282(3):164-7.
1990: Troels Herlin; Karsten Fogh; Ebbe S Hansen; A Andreasen; V Knudsen; T B Henriksen; C Bunger; Knud Kragballe
15-HETE inhibits leukotriene B4 formation and synovial cell proliferation in experimental arthritis.
Agents and actions 1990;29(1-2):52-3.
1990: L Halkier-Sørensen; M Cramers; Knud Kragballe
Twenty-nail dystrophy treated with topical PUVA.
Acta dermato-venereologica 1990;70(6):510-1.
1989: Frederik Grønhøj Larsen; F Nielsen-Kudsk; P Jakobsen; Knud Kragballe
Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis.
Pharmacology & toxicology 1989;65(5):393-7.
1989: Troels Herlin; Karsten Fogh; N O Christiansen; Knud Kragballe
Effect of auranofin on eicosanoids and protein kinase C in human neutrophils.
Agents and actions 1989;28(1-2):121-9.
1989: Karsten Fogh; Troels Herlin; Knud Kragballe
Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
The Journal of investigative dermatology 1989;92(6):837-41.
1989: Karsten Fogh; Ebbe S Hansen; Troels Herlin; V Knudsen; T B Henriksen; Henrik Ewald; C Bünger; Knud Kragballe
15-Hydroxy-eicosatetraenoic acid (15-HETE) inhibits carrageenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4).
Prostaglandins 1989;37(2):213-28.
1989: Karsten Fogh; Troels Herlin; Knud Kragballe
Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations.
The Journal of allergy and clinical immunology 1989;83(2 Pt 1):450-5.
1989: Knud Kragballe
Dietary supplementation with a combination of n-3 and n-6 fatty acids (super gamma-oil marine) improves psoriasis.
Acta dermato-venereologica 1989;69(3):265-8.
1989: L Halkier-Sørensen; Knud Kragballe; K Hansen
Antibodies to the Borrelia burgdorferi flagellum in patients with scleroderma, granuloma annulare and porphyria cutanea tarda.
Acta dermato-venereologica 1989;69(2):116-9.
1989: Knud Kragballe; C T Jansén; J M Geiger; J R Bjerke; E S Falk; L Gip; N Hjorth; J Lauharanta; N J Mork; T Reunala
A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
Acta dermato-venereologica 1989;69(1):35-40.
1989: Knud Kragballe; Karsten Fogh
A low-fat diet supplemented with dietary fish oil (Max-EPA) results in improvement of psoriasis and in formation of leukotriene B5.
Acta dermato-venereologica 1989;69(1):23-8.
1989: T Ternowitz; P H Andersen; Peter Bjerring; Karsten Fogh; Jens Schröder; Knud Kragballe
15-hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits the LTB4-induced skin response.
Archives of dermatological research 1989;281(6):401-5.
1989: Knud Kragballe
Topical corticosteroids: mechanisms of action.
Acta dermato-venereologica. Supplementum 1989;151():7-10; discussion 47-52.
1989: Knud Kragballe; Gary J Fisher; John J Voorhees
Modulators of cutaneous inflammation and proliferation in psoriasis.
Immunology series 1989;46():403-24.
1988: Karsten Fogh; Knud Kragballe; E Larsen; H Egsgaard; V K Shukla
Mass spectrometry of underivatized 15-hydroxyeicosatetraenoic acid and 15-hydroxyeicosapentaenoic acid.
Biomedical & environmental mass spectrometry 1988;17(6):459-61.
1988: Knud Kragballe; H I Beck; H Søgaard
Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study.
The British journal of dermatology 1988;119(2):223-30.
1988: Troels Herlin; Karsten Fogh; Henrik Ewald; Ebbe S Hansen; V E Knudsen; I Holm; Knud Kragballe; C Bunger
Changes in lipoxygenase products from synovial fluid in carrageenan induced arthritis in dogs.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1988;96(7):601-4.
1988: Troels Herlin; Karsten Fogh; V E Knudsen; Ebbe S Hansen; E Bunger; Henrik Ewald; I Holm; Knud Kragballe
Lipoxygenase products in experimental septic arthritis in dogs.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1988;96(7):596-600.
1988: Frederik Grønhøj Larsen; P Jakobsen; Christian Groenhoej Larsen; Knud Kragballe; F Nielsen-Kudsk
Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
Pharmacology & toxicology 1988;62(3):159-65.
1988: Karsten Fogh; H Søgaard; Troels Herlin; Knud Kragballe
Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxyeicosatetraenoic acid (15-HETE).
Journal of the American Academy of Dermatology 1988;18(2 Pt 1):279-85.
1988: T Ternowitz; Karsten Fogh; Knud Kragballe
15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1988;1(2):93-9.
1988: Karsten Fogh; Troels Herlin; Knud Kragballe
In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils.
Archives of dermatological research 1988;280(7):430-6.
1987: Frederik Grønhøj Larsen; P Jakobsen; Christian Groenhoej Larsen; A Nørgaard; Knud Kragballe; F Nielsen-Kudsk
Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.
Pharmacology & toxicology 1987;61(2):85-8.
1987: Knud Kragballe; E A Duell; John J Voorhees
Abnormal 15-hydroxyeicosatetraenoic acid (15-HETE) formation in psoriatic dermis.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():632-6.
1987: Karsten Fogh; J Kiil; Troels Herlin; T Ternowitz; Knud Kragballe
Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions.
Archives of dermatological research 1987;279(8):504-11.
1986: Karsten Fogh; T Ternowitz; Knud Kragballe; Troels Herlin
Chemotactic lipoxygenase products in sera from patients with psoriasis.
Archives of dermatological research 1986;278(3):173-6.
1985: Hugh Zachariae; M Cramers; Troels Herlin; J Jensen; Knud Kragballe; T Ternowitz; Kristian Thestrup-Pedersen
Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis.
Acta dermato-venereologica. Supplementum 1985;114():48-54.
1985: Troels Herlin; T Ternowitz; Knud Kragballe
Calcium efflux changes in neutrophils from patients with severe atopic dermatitis.
Acta dermato-venereologica. Supplementum 1985;120():50-2.
1982: M Cramers; J R Jensen; Knud Kragballe; Troels Herlin; Hugh Zachariae; Kristian Thestrup-Pedersen
Transfer factor in atopic dermatitis.
Dermatologica 1982;164(6):369-78.